NAGORE
GARCIA DE ANDOIN BARANDIARAN
PROFESORADO ASOCIADO
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadoras/es de Hospital de Cruces (8)
2021
-
Improved collection of hematopoietic stem cells and progenitors from Fanconi anemia patients for gene therapy purposes
Molecular Therapy - Methods and Clinical Development, Vol. 22, pp. 66-75
-
Protein Tyrosine Phosphatases in Neuroblastoma: Emerging Roles as Biomarkers and Therapeutic Targets
Frontiers in Cell and Developmental Biology, Vol. 9
2019
-
Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia
Nature Medicine, Vol. 25, Núm. 9, pp. 1396-1401
-
Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia
Pharmacogenomics Journal, Vol. 19, Núm. 6, pp. 564-569
2018
-
Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia
Pharmacogenomics Journal, Vol. 18, Núm. 6, pp. 704-712
-
Pharmacoepigenetics in childhood acute lymphoblastic leukemia: Involvement of miRNA polymorphisms in hepatotoxicity
Epigenomics, Vol. 10, Núm. 4, pp. 409-417
2016
-
Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia
Pharmacogenomics, Vol. 17, Núm. 7, pp. 731-741
2013
-
Polymorphisms in the methotrexate transport pathway: A new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia
Pharmacogenetics and Genomics, Vol. 23, Núm. 2, pp. 53-61